Lam Research Corporation
LAM RESEARCH CORP (Form: 3, Received: 05/30/2017 17:08:25)
FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Varadarajan Seshasayee

2. Date of Event Requiring Statement (MM/DD/YYYY)
5/22/2017 

3. Issuer Name and Ticker or Trading Symbol

LAM RESEARCH CORP [LRCX]

(Last)        (First)        (Middle)

C/O LAM RESEARCH CORPORATION, 4650 CUSHING PARKWAY

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Group Vice President /

(Street)

FREMONT, CA 94538       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock   86379   (1) D    
Common Stock   216   I   By 401(k)  

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Market-based Performance Restricted Stock Unit     (2)   (2) Common Stock   6203.0   (2) $0.0   D    
Market-based Performance Restricted Stock Unit     (3)   (3) Common Stock   7957.0   (3) $0.0   D    
Market-based Performance Restricted Stock Unit     (4)   (4) Common Stock   5180.0   (4) $0.0   D    
Stock Option (right to buy)   10/16/2012   10/16/2018   Common Stock   50.0   $13.54   D    

Explanation of Responses:
(1)  Amount reported includes shares subject to unvested Restricted Stock Units.
(2)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 2/11/18. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/2/15 to 2/2/18.
(3)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/19. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/1/16 to 2/1/19.
(4)  These Market-based Performance Restricted Stock Units vest between 0% and 150% on 3/1/20. The performance of this award is based on the Lam Research Total Shareholder Return performance relative to the Philadelphia Semiconductor Sector Index Total Shareholder Return during the performance period of 2/1/17 to 1/31/20.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Varadarajan Seshasayee
C/O LAM RESEARCH CORPORATION
4650 CUSHING PARKWAY
FREMONT, CA 94538


Group Vice President

Signatures
Leign Cramer by Power of Attorney 5/30/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
POWER OF ATTORNEY



The undersigned hereby constitutes and appoints each of Peter Ornowski, Corporate Controller, Brenna
Hodgson, Sr. Finance Manager, Leign Cramer, Stock Administrator, and George Schisler, Vice President
of General Legal Affairs, signing singly, to be the undersigned's true and lawful attorney-in-fact to:



(1) prepare, execute in my name and on my behalf, and submit to the United States Securities
and Exchange Commission (the "SEC") a Form ID, including amendments thereto, and any
other documents necessary or appropriate to obtain codes and passwords enabling me to
make electronic filings with the SEC of reports required by Section 16(a) of the Securities
Exchange Act of 1934 ("Section 16(a)") or any rule or regulation of the SEC;



(2) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer
and/or director of Lam Research Corporation (the "Company"), Forms 3, 4, and 5 in
accordance with Section 16(a) and the rules thereunder;



(3) do and perform any and all acts for and on behalf of the undersigned which may be
necessary or desirable to complete and execute any such Form 3, 4, or 5, complete and
execute any amendment or amendments thereto, and timely file such form with the SEC
and any stock exchange or similar authority; and



(4) take any other action of any type whatsoever in connection with the foregoing which, in the
opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally
required by, the undersigned, it being understood that the documents executed by such
attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in
such form and shall contain such terms and conditions as such attorney-in-fact may
approve in such attorney-in-fact's discretion.



The undersigned hereby grants to each such attorney-in-fact full power and authority to do and
perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise
of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might
or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming
all that such attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned
acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the
undersigned, are not assuming, nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act of 1934.



This Power of Attorney shall remain in full force and effect until the undersigned is no longer
required to file Forms 3, 4, and 5 with respect to the undersigned's holdings of and transactions in securities
issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.



IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of 17 May 2017.





/s/Sesha Varadarajan

 Signature



 Print Name: Sesha Varadarajan